The latest addition to the AtriClip product portfolio boasts the market's lowest profile surgical LAAM device, designed to enhance accessibility and positioning.
The new cryoSPHERE MAX Probe, for Post-Operative Pain Management, provides increased surface area coverage and 60 second freeze cycles to optimize the efficiency of the Cryo Nerve Block procedure.
Congratulations to Dr. Longoria & the @SHC_TriValley team on their first case with the AtriClip® FLEX-Mini™ device! Since 2010, Dr. Longoria has performed 2,000+ procedures with AtriClip to permanently exclude the LAA. Discover the next-generation device: https://t.co/3l5A3c1KiZ
Our manufacturing team is key to our mission, advancing Afib treatment and post-op pain management through their exceptional work. Watch Senior Principal Model Designer, Adam Harp, for an exclusive behind-the-scenes look at AtriCure’s manufacturing. #MFGDay2024
Introducing the AtriClip® FLEX-Mini™ device. The latest addition to our AtriClip® family features a closed-ended design that is 60% smaller than the next lowest profile clip on the market.
Learn more:https://t.co/jhBp6lj7ih
In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not.
Learn more:… https://t.co/FljiwKEfuS
Our manufacturing team is central to our mission. Whether it's on the assembly line or through welding, their exceptional work drives forward our advancements in Afib treatment and post-operative pain management.
Join us as Adam Harp, Senior Principal Model Designer, gives an exclusive behind-the-scenes look at what manufacturing at AtriCure is all about.
#MFGDay2024
If your IST symptoms are negatively affecting your quality of life, the HEAL-IST Trial is underway to evaluate the safety and effectiveness of a new hybrid ablation procedure to treat patients with symptomatic IST who are resistant or unable to tolerate medications.
Learn more at: https://okt.to/m2ndPf
We’re proud to stand with the American Heart Association in the fight against heart disease. From community walks to educational events, we’re committed to making a difference. Together, we can inspire healthier hearts everywhere. #AHA#WorldHeartDay
Physician Assistants, Nurse Practitioners, RN Coordinators, and other healthcare professionals gathered for our Cryo Nerve Block Therapy program today. We delved into the latest standards in analgesia and effective strategies for post-op pain relief, including #cryoNB as part of a multimodal approach. Thank you to all who joined us!
Interested in learning more about a non-opioid solution for post-operative pain? Learn more at: https://okt.to/J5fozM
#MedEd#cryoNB#PainManagement
Congratulations to Dr. James Longoria, M.D. and the Stanford Health Care Tri-Valley team on completing their first case with the AtriClip® FLEX-Mini™ device! Since 2010, Dr. Longoria has performed over 2,000 procedures with an AtriClip device to permanently exclude the LAA.
Explore the next-generation AtriClip device, the AtriClip FLEX-Mini: https://okt.to/P5dtpu#AtriClip#LAAE
Our manufacturing team is central to our mission. Whether it's on the assembly line or through welding, their exceptional work drives forward our advancements in Afib treatment and post-operative pain management.
Join us as Adam Harp, Senior Principal Model Designer, gives an exclusive behind-the-scenes look at what manufacturing at AtriCure is all about.
#MFGDay2024
At #APHRS2024, the CEASE-AF 24-month results were presented. The data demonstrated that Hybrid ablation with left atrial appendage exclusion is effective over the long term, with a ~33% absolute improvement in freedom from atrial arrhythmias* after 24 months of follow-up in patients with long-standing persistent Afib.**
Learn more about the CEASE AF Trial data: https://okt.to/cKo4mY
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib
social media channels to keep updated on the latest at AtriCure.
About the 3D Heart Education App
Duration: 00:37
AtriCure Patient Atrial Fibrillation Animation
Duration: 5:43
Sinus Rhythm Matters
Duration: 00:46
Vass’ Story with Afib and Hybrid AF Therapy
Duration: 4:49